Accordingly, there is growing evidence for the role of IgE antibodies in anti-tumour immunosurveillance, including an inverse association between serum IgE levels and the risk of gynaecological cancers including ovarian cancer [128]. Here, IGHE is linked to ovarian carcinoma.